UK fees for licensing medicines: easements for small companies

15 January 2007

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a statement saying that its fee legislation currently has provision for some payment easements for small companies in relation to a number of capital fees. Applications for payment easements must be made in writing to the Agency's finance department.

Under the MHRA's fees regulations (Reg 17, SI 1995 No 1116), a company will be eligible to be considered for the payment easements if, for the financial year before that in which the application is made:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight